Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Isthmus-preserving total bilobectomy: an adequate operation for C-cell hyperplasia.

Wahl RA, Vorländer C, Kriener S, Pedall J, Spitza M, Hansmann ML.

World J Surg. 2006 May;30(5):860-71.

PMID:
16680601
2.

Can sporadic medullary thyroid carcinoma be biochemically predicted? Prospective analysis of 66 operated patients with elevated serum calcitonin levels.

Iacobone M, Niccoli-Sire P, Sebag F, De Micco C, Henry JF.

World J Surg. 2002 Aug;26(8):886-90. Epub 2002 May 21.

PMID:
12016469
3.
4.

Incidental medullary thyroid microcarcinoma revealed by mild increase of preoperative serum calcitonin levels: therapeutic implications.

Boschin IM, Torresan F, Toniato A, Zane M, Ide EC, Pennelli G, Rampin L, Colletti PM, Rubello D, Pelizzo MR.

Endocrine. 2014 Apr;45(3):448-53. doi: 10.1007/s12020-013-0019-7. Epub 2013 Jul 25.

PMID:
23884895
5.

Early, Prophylactic Thyroidectomy in Hereditary Medullary Thyroid Carcinoma: A 26-year Monoinstitutional Experience.

Pelizzo MR, Torresan F, Boschin IM, Nacamulli D, Pennelli G, Barollo S, Rubello D, Mian C.

Am J Clin Oncol. 2015 Oct;38(5):508-13. doi: 10.1097/COC.0b013e3182a78fec.

PMID:
24064755
6.

Predictive value of pentagastrin test for preoperative differential diagnosis between C-cell hyperplasia and medullary thyroid carcinoma in patients with moderately elevated basal calcitonin levels.

Milone F, Ramundo V, Chiofalo MG, Severino R, Paciolla I, Pezzullo L, Lombardi G, Colao A, Faggiano A.

Clin Endocrinol (Oxf). 2010 Jul;73(1):85-8. doi: 10.1111/j.1365-2265.2009.03759.x. Epub 2009 Dec 18.

PMID:
20039894
7.

Surgical strategy for the treatment of medullary thyroid carcinoma.

Fleming JB, Lee JE, Bouvet M, Schultz PN, Sherman SI, Sellin RV, Friend KE, Burgess MA, Cote GJ, Gagel RF, Evans DB.

Ann Surg. 1999 Nov;230(5):697-707. Review.

8.

Prophylactic thyroidectomy for MEN 2-related medullary thyroid carcinoma based on predictive testing for RET proto-oncogene mutation and basal serum calcitonin in China.

Qi XP, Zhao JQ, Du ZF, Yang RR, Ma JM, Fei J, Cheng J, Han JS, Jin HY, Chen ZG, Wang JQ, Yang YP, Ying RB, Chen XL, Liu WT, Zhao Y, Jiang HL, Zhang XN.

Eur J Surg Oncol. 2013 Sep;39(9):1007-12. doi: 10.1016/j.ejso.2013.06.015. Epub 2013 Jul 9.

PMID:
23849459
9.

[Total thyroidectomy in C-cell hyperplasia of the thyroid gland].

Stojanović D, Paunović I, Caparević Z, Lalosević D, Stojanović M.

Med Pregl. 2003 Sep-Oct;56(9-10):481-4. Serbian.

PMID:
14740541
10.

Medullary thyroid carcinoma: results of a standardized surgical approach in a contemporary series of 80 consecutive patients.

Yen TW, Shapiro SE, Gagel RF, Sherman SI, Lee JE, Evans DB.

Surgery. 2003 Dec;134(6):890-9; discussion 899-901.

PMID:
14668720
11.

Thyroid morphology and function after surgical treatment of thyroid diseases.

Mann B, Schmale P, Stremmel W.

Exp Clin Endocrinol Diabetes. 1996;104(3):271-7.

PMID:
8817246
12.

Total thyroidectomy for benign thyroid disease.

Liu Q, Djuricin G, Prinz RA.

Surgery. 1998 Jan;123(1):2-7.

PMID:
9457216
13.

[Prophylactic thyroidectomy in children who are carriers of a multiple endocrine neoplasia type 2 mutation: description of 20 cases and recommendations based on the literature].

de Groot JW, Links TP, Rouwe CW, van der Wal JE, Hofstra RM, Plukker JT.

Ned Tijdschr Geneeskd. 2006 Feb 11;150(6):311-8. Review. Dutch.

PMID:
16503023
14.

Long-term outcome of "prophylactic therapy" for familial medullary thyroid cancer.

Schellhaas E, König C, Frank-Raue K, Buhr HJ, Hotz HG.

Surgery. 2009 Nov;146(5):906-12. doi: 10.1016/j.surg.2009.06.007. Epub 2009 Jul 15.

PMID:
19744457
15.

Association of Basal and Calcium-stimulated Calcitonin Levels with Pathological Findings After Total Thyroidectomy.

Papadakis G, Keramidas I, Triantafillou E, Kanouta F, Pappa T, Kaltzidou V, Tertipi A, Iordanidou L, Trivizaki E, Vecchini G, Villiotou V, Pappas A.

Anticancer Res. 2015 Jul;35(7):4251-8.

PMID:
26124386
16.

C-cell hyperplasia and medullary thyroid carcinoma in patients routinely screened for serum calcitonin.

Kaserer K, Scheuba C, Neuhold N, Weinhäusel A, Vierhapper H, Haas OA, Niederle B.

Am J Surg Pathol. 1998 Jun;22(6):722-8.

PMID:
9630179
17.

Primary hereditary medullary thyroid carcinoma--C-cell morphology and correlation with preoperative calcitonin levels.

Hinze R, Holzhausen HJ, Gimm O, Dralle H, Rath FW.

Virchows Arch. 1998 Sep;433(3):203-8.

PMID:
9769122
18.

Prophylactic thyroidectomy in ethnic Chinese patients with multiple endocrine neoplasia type 2A syndrome after the introduction of genetic testing.

Lau GS, Lang BH, Lo CY, Tso A, Garcia-Barcelo MM, Tam PK, Lam KS.

Hong Kong Med J. 2009 Oct;15(5):326-31.

19.

Surgical strategy for the treatment of sporadic medullary thyroid carcinoma: our experience.

Lupone G, Antonino A, Rosato A, Zenone P, Iervolino EM, Grillo M, De Palma M.

G Chir. 2012 Nov-Dec;33(11-12):395-9.

PMID:
23140924
20.

[Clinical diagnosis and treatment of familial medullary thyroid carcinoma caused by a p.C618Y RET proto-oncogene mutation in a Chinese pedigree].

Zhao JQ, Guo L, Qi XP, Chen ZG, Wang KJ, Lou JL, Yu XH, Cheng J, Jin HY, Li XL, Ying RB, Zhang XN.

Zhonghua Yi Xue Za Zhi. 2013 Feb 5;93(6):440-4. Chinese.

PMID:
23660264

Supplemental Content

Support Center